CARDIFF ONCOLOGY INC shareholders Q2 2023

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 54 filers reported holding CARDIFF ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

CARDIFF ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 7,799$11,4650.00%
NORTHERN TRUST CORP 72,386$106,4070.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 27,976$41,1250.00%
GEODE CAPITAL MANAGEMENT, LLC 381,150$560,2900.00%
STATE STREET CORP 139,945$205,7190.00%
Eagle Bay Advisors LLC 339$4980.00%
PRICE T ROWE ASSOCIATES INC /MD/ 36,500$540.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 16,399$24,1070.00%
MORGAN STANLEY 15,713$23,0980.00%
BlackRock Inc. 760,272$1,117,6000.00%
Bank of New York Mellon Corp 14,350$21,0940.00%
Citadel Advisors 10,100$14,8470.00%
Citadel Advisors 86,123$126,6010.00%
CAPSTONE INVESTMENT ADVISORS, LLC 51,190$75,2490.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 94,504$138,9210.00%
HighTower Advisors, LLC 15,333$22,0000.00%
Front Row Advisors LLC 2$00.00%
Financial Gravity Asset Management, Inc. 1$20.00%
Global Retirement Partners, LLC 350$5150.00%
External links

This page lists CARDIFF ONCOLOGY INC's shareholders in Q2 2023. To view CARDIFF ONCOLOGY INC's shareholder history, click here.